A61P 17 - Drugs for dermatological disorders

Patents for A61P 17 - Drugs for dermatological disorders (106,455)
10/2009
10/22/2009	US20090264339 Heterocyclic Compounds
10/22/2009	US20090264291 Compositions comprising anti-proliferative agents and use thereof
10/22/2009	US20090263518 Composition and Uses Thereof
10/22/2009	US20090263500 Composition and method for treating bedsores, cuts and burns
10/22/2009	US20090263474 Methods for Treating Autoimmune Diseases in a Subject and In Vitro Diagnostic Assays
10/22/2009	US20090263466 Herbal composition for treatment of hyperlipidemia and the inhibition of myocardial infarction
10/22/2009	US20090263429 Method of Preparing a Hydrogel
10/22/2009	US20090263415 Composition for scalp and hair of scalp
10/22/2009	US20090263401 USES OF IL-174 ANTAGONISTS FOR INHIBITING A Th2 IMMUNE RESPONSE
10/22/2009	US20090263367 Composition and method for promoting internal health and external appearance
10/22/2009	US20090263341 Soft anticholinergic esters
10/22/2009	US20090263340 Cosmetic compositions
10/22/2009	US20090263339 Agent for external application to the skin
10/22/2009	DE102008019303A1 Skin protection composition, useful e.g. as agent for preventing or treating callus and blisters, comprises a polymerization mixture, which is hardenable under the influence of light, e.g. polyester(meth)acrylate or polyolacrylate
10/22/2009	CA2721507A1 Methods of generating and using procollagen
10/22/2009	CA2721339A1 Activating agent for peroxisome proliferator activated receptor
10/22/2009	CA2721335A1 Process for preparing bioabsorbable sheet preparation holding thrombin
10/21/2009	EP2110142A2 Inhibition of secretion from non-neuronal cells
10/21/2009	EP1988909B1 Use of polyethylene glycol in inflammation related topical disorders or diseases and wound healing
10/21/2009	EP1776138B1 tRNA SYNTHETASE FRAGMENTS
10/21/2009	EP1513531B1 Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom
10/21/2009	EP1512404B1 External preparations for treating dermatitis
10/21/2009	EP1492785B9 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors
10/21/2009	EP1450750B1 Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase
10/21/2009	EP1311238B1 Use of di-sugar alcohol phosphates to protect human skin cells from uv-and/or ir radiation
10/21/2009	EP1280776B1 Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis
10/21/2009	EP1187598B1 Micropigment mixture
10/21/2009	EP1164991B1 Gels formed by the interaction of poly(aldehyde) with various substances
10/21/2009	EP1162968B1 Epigallocatechin-gallate for inhibiting angiogenesis
10/21/2009	CN101563082A Composition and method for treating immune-mediated skin disorders
10/21/2009	CN101563073A Use of nepafenac or derivatives thereof for treating dermatological disorders linked with a keratinisation disorder that may include an inflammatory immuno-allergic component
10/21/2009	CN101560546A Application of Phosphatidylinositol4-kinase type II alpha PI4KIIalpha
10/21/2009	CN101560529A Arachidonic acid and methods for the production and use thereof
10/21/2009	CN101560213A Polycyclic compound functioned as inhibitor of enzyme parp, vegfr2 and mlk3 and the application
10/21/2009	CN101559215A Skin physiology repair liquid and preparation method thereof
10/21/2009	CN101559210A Chinese materia medica preparation for treating alopecia areata
10/21/2009	CN101559209A Chinese materia medica preparation for treating urticaria
10/21/2009	CN101559202A Zedoary turmeric oil adhesive membrane for external application and preparation method thereof
10/21/2009	CN101559188A Traditional Chinese medicine compound preparation used for treating colpitis and tinea manus and pedis and preparation method thereof
10/21/2009	CN101559184A Chinese materia medica preparation for treating eczema
10/21/2009	CN101559171A Traditional Chinese medicine for dispelling freckles
10/21/2009	CN101559168A Pharmaceutical composition for invigorating Qi, tonifying blood and nourishing liver and kidney as well as preparation method and application thereof
10/21/2009	CN101559164A Chinese materia medica preparation for treating granuloma
10/21/2009	CN101559149A Application of dragon blood and dragon-blood extract
10/21/2009	CN101559143A Chinese materia medica preparation for treating lupus erythematosus
10/21/2009	CN101559141A Chinese materia medica preparation for treating vitiligo
10/21/2009	CN101559136A Combined medicament for treating tinea corporis and tinea manus and pedis and preparation method thereof
10/21/2009	CN101559135A Medicine composition for treating burn wound and preparation method thereof
10/21/2009	CN101559134A Chinese materia medica preparation for treating rosacea
10/21/2009	CN101559133A Preparation of pure traditional medicine preparation for curing scleroderma
10/21/2009	CN101559131A Traditional Chinese medicinal composition for treating scabies and preparation method thereof
10/21/2009	CN101559129A Chinese materia medica preparation for treating seborrheic dermatitis
10/21/2009	CN101559125A Burning powder
10/21/2009	CN101559120A Traditional Chinese medicinal ointment for treating radioepidermitis
10/21/2009	CN101559117A Antipruritic oil
10/21/2009	CN101559116A Stable Chinese medicinal freckle-removing soft capsule and preparation method thereof
10/21/2009	CN101559108A Chinese medicinal preparation for treating beriberi, tinea corporis, tinea cruris and method for preparing same
10/21/2009	CN101559107A Chinese materia medica preparation for treating folliculitis
10/21/2009	CN101559104A Prescription of pure traditional Chinese medicine preparation for curing prematured white hair
10/21/2009	CN101559103A Sterilizing and itching-relieving medical composition
10/21/2009	CN101559102A Chinese materia medica preparation for treating psoriasis
10/21/2009	CN101559096A Verruca-eliminating liquid medicine and preparation method thereof
10/21/2009	CN101559063A External medicament for curing herpes zoster and preparation method thereof
10/21/2009	CN101559051A Use of butin and derivatives thereof for preparing drugs having inhibitive effect on melanoma
10/21/2009	CN101559050A Use of butin and derivatives thereof for preparing drugs having inhibitive effect on immune system
10/21/2009	CN101559047A Function of xylitol erythritol in wound irrigation
10/21/2009	CN101559038A Solid lipid nanoparticles of finasteride and preparation method thereof
10/21/2009	CN100551916C Novel 2,4-diamino-1,3,5-triazine derivative
10/21/2009	CN100551411C Medicine powder for healing wound fast
10/21/2009	CN100551401C Chinese-medicinal composition for treating osmidrosis
10/21/2009	CN100551395C Traditional Chinese medicine for treating exogenous injury of human body
10/21/2009	CN100551394C Medicine for treating psoriasis
10/21/2009	CN100551385C Externally used traditional Chinese medicine and its preparing process
10/21/2009	CN100551348C External compositions for the skin
10/20/2009	US7605173 Pharmaceutical liquid composition containing pyridone derivative
10/20/2009	US7605167 Use of cyclopamine in the treatment of psoriasis
10/20/2009	US7605152 such as 16 alpha -fluoro-17 beta -hydroxy-4-methyl-4-aza-5 alpha -androst-1-en-3-one, used for hormone replacement therapy
10/20/2009	US7605140 Endothelial growth factors; antiischemic agents; neovascularization
10/20/2009	US7604949 For skin lightening or darkening; cell-free; drug screening
10/20/2009	US7604821 Fresh water sponge with excipient
10/20/2009	US7604812 For the treatment of dry, sensitive skin. Despite being free from such ingredients as perfumes, preservatives, colorings, plant extracts, PEGs, cetylstearyl alcohol, lanolin alcohol, lower alcohols and proteins
10/20/2009	US7604806 Topically applied cosmetic/pharmaceutical with a protective/regenerating effect wherethe plant cells are Criste marine (Crithmum maritimum); enzyme inhibitors of tyrosinase; free radical scavengers; stimulants for cell proliferation of the epidermal basal layer; inhibition of epidermal differentiation
10/20/2009	CA2451923C Botulinum toxin in the treatment or prevention of acne
10/20/2009	CA2415782C Dermatological composition comprising a multiplicity of particles
10/20/2009	CA2408142C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
10/20/2009	CA2385130C Novel spiroheterocyclic compounds useful as reversible inhibitors of cysteine proteases
10/20/2009	CA2358951C Reverse hydroxamate inhibitors of matrix metalloproteinases
10/20/2009	CA2328114C Hair colorant composition
10/20/2009	CA2306214C Plaster for topical use containing heparin and diclofenac
10/15/2009	WO2009126349A2 Methods and compositions related to internalizing rgd peptides
10/15/2009	WO2009126302A2 Stabilized oleosome preparations and methods of making them
10/15/2009	WO2009126301A2 Controlled release of active agents from oleosomes
10/15/2009	WO2009125447A2 Treatment for the hair regrowth in the bald patches formed by alopecia of the celsi area
10/15/2009	WO2009125182A1 A product for topical administration
10/15/2009	WO2009125117A2 Dermatological composition that can be used in particular for the care and prevention of eschars
10/15/2009	WO2009125017A2 Process for the extraction of mangiferin and isomangiferin
10/15/2009	WO2009111695A8 Methods of increasing epidermal skin thickness by topical administration of a 19-nor containing vitamin d compound
10/15/2009	WO2009105294A3 Topical compositions and methods for whitening skin
10/15/2009	WO2009103959A3 Histidine and/or histidine derivative for the treatment of inflammatory skin diseases
10/15/2009	WO2009065920A3 Compounds

1 ... 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 ... 1065